Last updated: 2026-09-15 13:25:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $64.11, with a market capitalization of $130.00B and a P/E ratio of 14.11. Over the past 52 weeks, its price has ranged from $42.52 to $68.64. This page covers its latest market performance, valuation, price trends and company information.
$130.00B | |
$64.12 | |
$81.44 | |
$16.00 | |
$64.10 | |
2.89K | |
11.19M | |
14.11 | |
$68.64 | |
$42.52 | |
3.89% | |
-- |
Bristol-Myers Squibb Co. (BMY) is trading at $64.11 in pre-market trading as of 2026-09-15 13:08:03, up 0.02% ($0.01) from the previous close of $64.10
Pre-market trading shows how investors are pricing BMY before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $68.09 to $64.11, representing a decline of 5.85% ($3.98).
The stock traded between $63.27 and $68.24 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 6.80 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 82.7%
BMY is currently trading at $64.11, placing it 82.7% of the way from its 52-week low of $42.52 to its 52-week high of $68.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.